Lpl Financial LLC Madrigal Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 4,740 shares of MDGL stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,740

Previous 5,178 8.46%

Holding current value

$1.6 Million

Previous $1.45 Million 30.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$212.22 - $292.96 $92,952 - $128,316	-438 Reduced 8.46%	4,740 $1.01 Million
Q2 2024 Aug 07, 2024	BUY	$193.33 - $291.99 $338,134 - $510,690	1,749 Added 51.01%	5,178 $1.45 Million
Q1 2024 May 10, 2024	SELL	$171.37 - $283.23 $24,505 - $40,501	-143 Reduced 4.0%	3,429 $915,000
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $430,068 - $847,028	3,572 New	3,572 $826,000
Q2 2023 Jul 31, 2023	BUY	$203.88 - $312.0 $37,513 - $57,408	184 Added 22.28%	1,010 $233,000
Q1 2023 May 10, 2023	SELL	$231.06 - $307.08 $13,170 - $17,503	-57 Reduced 6.46%	826 $200,000
Q4 2022 Feb 07, 2023	BUY	$58.39 - $296.54 $51,558 - $261,844	883 New	883 $256,000
Q2 2022 Aug 12, 2022	SELL	$58.04 - $100.2 $218,694 - $377,553	-3,768 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$55.89 - $101.89 $210,593 - $383,921	3,768 New	3,768 $370,000
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $203,492 - $267,488	-2,813 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $16,061 - $21,529	-205 Reduced 6.79%	2,813 $224,000
Q2 2021 Aug 13, 2021	BUY	$97.2 - $137.59 $65,610 - $92,873	675 Added 28.81%	3,018 $294,000
Q1 2021 May 14, 2021	BUY	$108.54 - $125.2 $254,309 - $293,343	2,343 New	2,343 $274,000
Q1 2019 May 08, 2019	SELL	$103.48 - $143.84 $233,864 - $325,078	-2,260 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$94.77 - $215.54 $89,747 - $204,116	947 Added 72.12%	2,260 $255,000
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $2,073 - $3,003	-10 Reduced 0.76%	1,313 $281,000
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $134,350 - $415,289	1,323 New	1,323 $370,000

Others Institutions Holding MDGL

# of Institutions

298

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.76B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Madrigal Pharmaceuticals, Inc. Transaction History